Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125221) titled 'A Study on Blood Biomarkers in Sepsis Patients in Relation to Diagnosis, Prognosis and Treatment' on May 22.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Tianjin Nankai Hospital
Condition:
Sepsis
Intervention:
Sepsis group:No
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-11-30
Target Sample Size: Sepsis group:400;healthy controls group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=314739
Published by HT Digital Content Services with permission from Health Daily Digest....